| Time | Session |
|---|
|
15:20
15:45
|
Modeling cachexia in mice: from intestinal cancer models to distinct host trajectories
|
|
15:45
15:55
|
Proffered Paper: Oncolytic virus (CVA21) in combination with pembrolizumab increases tumour cell immunogenicity and remodels the tumour microenvironment in advanced NSCLC: a phase I/II trial
EACR25-1995
|
|
15:55
16:20
|
Insights into cancer cachexia from the TRACERx lung cancer study
|
|
16:20
16:30
|
Proffered Paper: Translational control shapes Treg cell fate in the tumor microenvironment
EACR25-2124
|
|
16:30
16:55
|
Exploring the tumor MACROenvironment for improving cancer diagnosis and therapy
|